Advertisement

Topics

American CAR-T Leader Eyes Europe, Initiating Market Approval Process & Clinical Trial

05:25 EDT 8 Aug 2017 | Labiotech.eu

Kite is charging ahead in Europe with a clinical trial and marketing authorization application as Novartis leads in the American CAR-T race. Novartis has claimed the position as the frontrunner in the CAR-T race, having just earned the unanimous recommendation ...

This awesome article American CAR-T Leader Eyes Europe, Initiating Market Approval Process & Clinical Trial appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: American CAR-T Leader Eyes Europe, Initiating Market Approval Process & Clinical Trial

NEXT ARTICLE

More From BioPortfolio on "American CAR-T Leader Eyes Europe, Initiating Market Approval Process & Clinical Trial"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...